miR-342 overexpression results in a synthetic lethal phenotype in <i>BRCA1</i>-mutant HCC1937 breast cancer cellsElisabetta Crippa(Fondazione IRCCS Istituto Nazionale dei Tumori), Manuela Gariboldi(IFOM)OncotargetFebruary 23, 201610.18632/oncotarget.7617Cited by 23SaveCiteExport RISWatch citationsRelated PapersMetformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production|Scientific Reports|2017|130miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer|PLoS ONE|2014|66